Overview

A Trial of Tadalafil and Glycemic Traits

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if tadalafil can help overweight and obese people metabolize blood sugar more efficiently. The investigators also want to find out if 20 mg/day of tadalafil for 3 months is safe to take without causing too many side effects. The investigators are plan to enroll 100 subjects at Massachusetts General Hospital (MGH).
Phase:
Phase 3
Details
Lead Sponsor:
Thomas J. Wang, MD
Treatments:
Phosphodiesterase 5 Inhibitors
Tadalafil